Literature DB >> 10686356

Fragile X (fmr1) mRNA expression is differentially regulated in two adult models of activity-dependent gene expression.

G Valentine1, S Chakravarty, J Sarvey, C Bramham, M Herkenham.   

Abstract

We sought to determine whether the fragile X mental retardation gene fmr1 is regulated in long-term potentiation (LTP) and electroconvulsive shock (ECS). In situ hybridization of fmr1 mRNA in hippocampus of rats given LTP in vivo showed no change in fmr1 mRNA levels relative to control. However, ECS induced a selective increase in fmr1 mRNA expression in the dentate gyrus (DG) granule cell layer at 6 h post-ECS. The ECS paradigm may unmask relevant activity-dependent regulatory mechanisms that modulate fmr1 gene transcription in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686356     DOI: 10.1016/s0169-328x(99)00310-1

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  4 in total

1.  Tamalin is a critical mediator of electroconvulsive shock-induced adult neuroplasticity.

Authors:  Sudhirkumar U Yanpallewar; Colleen A Barrick; Mary Ellen Palko; Gianluca Fulgenzi; Lino Tessarollo
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

2.  The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophila mushroom body neurons.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Neurobiol Dis       Date:  2010-09-16       Impact factor: 5.996

3.  Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.

Authors:  Laura N Antar; Rownak Afroz; Jason B Dictenberg; Reed C Carroll; Gary J Bassell
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

4.  Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Development       Date:  2008-03-05       Impact factor: 6.868

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.